19-55401610-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_014501.3(UBE2S):c.495C>T(p.Ala165=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,606,292 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0059 ( 10 hom., cov: 32)
Exomes 𝑓: 0.00062 ( 10 hom. )
Consequence
UBE2S
NM_014501.3 synonymous
NM_014501.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.77
Genes affected
UBE2S (HGNC:17895): (ubiquitin conjugating enzyme E2 S) This gene encodes a member of the ubiquitin-conjugating enzyme family. The encoded protein is able to form a thiol ester linkage with ubiquitin in a ubiquitin activating enzyme-dependent manner, a characteristic property of ubiquitin carrier proteins. [provided by RefSeq, Jul 2008]
RPL28 (HGNC:10330): (ribosomal protein L28) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L28E family of ribosomal proteins. It is located in the cytoplasm. Variable expression of this gene in colorectal cancers compared to adjacent normal tissues has been observed, although no correlation between the level of expression and the severity of the disease has been found. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 19-55401610-G-A is Benign according to our data. Variant chr19-55401610-G-A is described in ClinVar as [Benign]. Clinvar id is 716611.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.77 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00585 (891/152282) while in subpopulation AFR AF= 0.0199 (827/41564). AF 95% confidence interval is 0.0188. There are 10 homozygotes in gnomad4. There are 445 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 891 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBE2S | NM_014501.3 | c.495C>T | p.Ala165= | synonymous_variant | 4/4 | ENST00000264552.14 | NP_055316.2 | |
RPL28 | NM_001363697.1 | c.325-1333G>A | intron_variant | NP_001350626.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBE2S | ENST00000264552.14 | c.495C>T | p.Ala165= | synonymous_variant | 4/4 | 1 | NM_014501.3 | ENSP00000264552 | P1 | |
UBE2S | ENST00000587845.5 | c.582C>T | p.Ala194= | synonymous_variant | 5/5 | 2 | ENSP00000467409 | |||
RPL28 | ENST00000560055.5 | c.325-1333G>A | intron_variant | 3 | ENSP00000452763 |
Frequencies
GnomAD3 genomes AF: 0.00584 AC: 888AN: 152164Hom.: 10 Cov.: 32
GnomAD3 genomes
AF:
AC:
888
AN:
152164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00145 AC: 329AN: 226812Hom.: 2 AF XY: 0.00116 AC XY: 146AN XY: 125616
GnomAD3 exomes
AF:
AC:
329
AN:
226812
Hom.:
AF XY:
AC XY:
146
AN XY:
125616
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000616 AC: 896AN: 1454010Hom.: 10 Cov.: 30 AF XY: 0.000561 AC XY: 406AN XY: 723128
GnomAD4 exome
AF:
AC:
896
AN:
1454010
Hom.:
Cov.:
30
AF XY:
AC XY:
406
AN XY:
723128
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00585 AC: 891AN: 152282Hom.: 10 Cov.: 32 AF XY: 0.00598 AC XY: 445AN XY: 74450
GnomAD4 genome
AF:
AC:
891
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
445
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 14, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at